115 related articles for article (PubMed ID: 24787960)
1. Regulatory role of nucleophosmin during the differentiation of human liver cancer cells.
Xu DH; Liu F; Li X; Chen XF; Jing GJ; Wu FY; Shi SL; Li QF
Int J Oncol; 2014 Jul; 45(1):264-72. PubMed ID: 24787960
[TBL] [Abstract][Full Text] [Related]
2. A novel interaction of nucleophosmin with BCL2-associated X protein regulating death evasion and drug sensitivity in human hepatoma cells.
Lo SJ; Fan LC; Tsai YF; Lin KY; Huang HL; Wang TH; Liu H; Chen TC; Huang SF; Chang CJ; Lin YJ; Yung BY; Hsieh SY
Hepatology; 2013 May; 57(5):1893-905. PubMed ID: 23258611
[TBL] [Abstract][Full Text] [Related]
3. Localization of nucleophosmin in nuclear matrix and changes in its expression during the differentiation of human neuroblastoma induced by retinoic acid.
Shi SL; Liang Y; Li QF; Liu QR; Jing GJ; Wang SY; Zhang XY; Wu FY
J Cell Biochem; 2010 Sep; 111(1):67-74. PubMed ID: 20506166
[TBL] [Abstract][Full Text] [Related]
4. Localization and altered expression of nucleophosmin in the nuclear matrix during the differentiation of human hepatocarcinoma SMMC-7721 cells induced by HMBA.
Li QF; Tang J; Liu QR; Shi SL; Chen XF
Cancer Invest; 2010 Dec; 28(10):1004-12. PubMed ID: 20690796
[TBL] [Abstract][Full Text] [Related]
5. Relocation of NPM Affects the Malignant Phenotypes of Hepatoma SMMC-7721 Cells.
Li X; Xu DH; Liu F; Liu GY; Lu K; Deng XL; Li QF; Shi SL
J Cell Biochem; 2017 Oct; 118(10):3225-3236. PubMed ID: 28262969
[TBL] [Abstract][Full Text] [Related]
6. Nucleophosmin interacts with FOXM1 and modulates the level and localization of FOXM1 in human cancer cells.
Bhat UG; Jagadeeswaran R; Halasi M; Gartel AL
J Biol Chem; 2011 Dec; 286(48):41425-41433. PubMed ID: 21979956
[TBL] [Abstract][Full Text] [Related]
7. Low-Dose Actinomycin-D Induces Redistribution of Wild-Type and Mutated Nucleophosmin Followed by Cell Death in Leukemic Cells.
Brodská B; Holoubek A; Otevřelová P; Kuželová K
J Cell Biochem; 2016 Jun; 117(6):1319-29. PubMed ID: 26505272
[TBL] [Abstract][Full Text] [Related]
8. GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer.
Kim JY; Cho YE; An YM; Kim SH; Lee YG; Park JH; Lee S
J Cell Mol Med; 2015 Jun; 19(6):1245-52. PubMed ID: 25818168
[TBL] [Abstract][Full Text] [Related]
9. MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia.
Xie J; Briggs JA; Morris SW; Olson MO; Kinney MC; Briggs RC
Exp Hematol; 1997 Oct; 25(11):1111-7. PubMed ID: 9328447
[TBL] [Abstract][Full Text] [Related]
10. Involvement of nucleophosmin/B23 in the cellular response to curcumin.
Weng CH; Yung BY; Weng JJ; Wu MH
J Nutr Biochem; 2011 Jan; 22(1):46-52. PubMed ID: 20303727
[TBL] [Abstract][Full Text] [Related]
11. RNA aptamers interfering with nucleophosmin oligomerization induce apoptosis of cancer cells.
Jian Y; Gao Z; Sun J; Shen Q; Feng F; Jing Y; Yang C
Oncogene; 2009 Nov; 28(47):4201-11. PubMed ID: 19734942
[TBL] [Abstract][Full Text] [Related]
12. [Differentiation of human hepatocarcinoma SMMC-7721 cells induced by HMBA].
Ouyang GL; Li QF; Peng XX; Hong SG
Shi Yan Sheng Wu Xue Bao; 2001 Dec; 34(4):269-73. PubMed ID: 12549204
[TBL] [Abstract][Full Text] [Related]
13. Alteration of nuclear matrix-intermediate filament system and differential expression of nuclear matrix proteins during human hepatocarcinoma cell differentiation.
Tang J; Niu JW; Xu DH; Li ZX; Li QF; Chen JA
World J Gastroenterol; 2007 May; 13(20):2791-7. PubMed ID: 17569113
[TBL] [Abstract][Full Text] [Related]
14. Global functional analysis of nucleophosmin in Taxol response, cancer, chromatin regulation, and ribosomal DNA transcription.
Bergstralh DT; Conti BJ; Moore CB; Brickey WJ; Taxman DJ; Ting JP
Exp Cell Res; 2007 Jan; 313(1):65-76. PubMed ID: 17069796
[TBL] [Abstract][Full Text] [Related]
15. Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants.
Bolli N; Nicoletti I; De Marco MF; Bigerna B; Pucciarini A; Mannucci R; Martelli MP; Liso A; Mecucci C; Fabbiano F; Martelli MF; Henderson BR; Falini B
Cancer Res; 2007 Jul; 67(13):6230-7. PubMed ID: 17616680
[TBL] [Abstract][Full Text] [Related]
16. Anticancer effects of ginsenoside Rg1, cinnamic acid, and tanshinone IIA in osteosarcoma MG-63 cells: nuclear matrix downregulation and cytoplasmic trafficking of nucleophosmin.
Li QF; Shi SL; Liu QR; Tang J; Song J; Liang Y
Int J Biochem Cell Biol; 2008; 40(9):1918-29. PubMed ID: 18403247
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells.
Lin M; Hu J; Liu T; Li J; Chen B; Chen X
Immunobiology; 2013 Sep; 218(9):1147-54. PubMed ID: 23669237
[TBL] [Abstract][Full Text] [Related]
18. The Nucleolar Protein GLTSCR2 Is an Upstream Negative Regulator of the Oncogenic Nucleophosmin-MYC Axis.
Kim JY; Cho YE; Park JH
Am J Pathol; 2015 Jul; 185(7):2061-8. PubMed ID: 25956029
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signal.
Mariano AR; Colombo E; Luzi L; Martinelli P; Volorio S; Bernard L; Meani N; Bergomas R; Alcalay M; Pelicci PG
Oncogene; 2006 Jul; 25(31):4376-80. PubMed ID: 16501600
[TBL] [Abstract][Full Text] [Related]
20. NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells.
Qi W; Shakalya K; Stejskal A; Goldman A; Beeck S; Cooke L; Mahadevan D
Oncogene; 2008 Jul; 27(30):4210-20. PubMed ID: 18345031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
